GSS 1.39% 73.0¢ genetic signatures limited

Ann: Presenting at Bell potter healthcare conference, page-11

  1. Al.
    198 Posts.
    lightbulb Created with Sketch. 114
    Roche targets 2 vs GSS 12; as singular tests this chops cost to Medicare down from potentially $252 plus GP visits + additional costs from failure to diagnose lack of early treatment
    Abbott 4 vs GSS 12
    qiagen 1 vs GSS 12
    IMHO the real value long term to governments that fund reproductive assistance is the reduction in long term fertility issues by the use of screening - as opposed to stab in the dark individual testing - the superficial symptoms go away the testing stops the condition moves to PID - and LT infertility issues
 
watchlist Created with Sketch. Add GSS (ASX) to my watchlist
(20min delay)
Last
73.0¢
Change
0.010(1.39%)
Mkt cap ! $165.3M
Open High Low Value Volume
71.5¢ 73.0¢ 71.0¢ $373.9K 519.6K

Buyers (Bids)

No. Vol. Price($)
1 1 71.0¢
 

Sellers (Offers)

Price($) Vol. No.
73.0¢ 9999 1
View Market Depth
Last trade - 16.10pm 10/07/2024 (20 minute delay) ?
GSS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.